Previously, we have described a technically similar engineered pancreatic adenocarcinoma cell line (opto-TLR4 PANC-1) that allows time- and voltage-dependent TLR4 activation by blue light, which can be switched off again in the dark. The gene discussed is TLR4; the disease is pancreatic adenocarcinoma.